人混合肝细胞（Heps 20）

人混合原代肝细胞（hp2heps）为药物试验和药物开发提供了理想的培养模型。HP2-10人混合原代肝细胞含有来自10个不同供体的冷冻保存肝细胞，只冷冻了一次。混合肝细胞提供了必要的遗传多样性，以保证试验化合物相对于代表群体的代谢特征具有更高的可靠性和可预测性。混合肝细胞通过消除获得基于群体的数据所需的冗余实验来增加实验控制并降低成本。每个批次都经历了一个单独的冷冻循环，以确保最大限度的肝细胞活力和供体之间的一致性。细胞特征：每个供者的肝细胞分离纯化后立即冷冻保存。混合的有10到20个捐赠者。每一个供体都由一个统计上显著的细胞数来表示。有广泛的质量控制提供生存能力和酶活性的特征，从个人捐助者到整个库。AcceGen保证性能和质量，提供捐赠者信息。

Human Pooled Primary Hepatocytes (HP2 Heps) provide an ideal culture model for drug testing and drug development. HP2 10 Human Pooled Primary Hepatocytes contain cryopreserved hepatocytes pooled from 10 different donors and have undergone only one freeze cycle. Pooled hepatocytes provide the genetic diversity necessary for superior reliability and predictability of the metabolic characteristics of a test compound relative to a representative population. Pooled hepatocytes increase experimental control and reduce costs by eliminating the need to conduct redundant experiments necessary to obtain population-based data. Each lot has undergone a single freeze cycle, assuring maximum hepatocyte viability and consistency from donor to donor within the pool. Cell Features: Each donor's hepatocytes have been cryopreserved ONCE immediately after isolation and purification. Pools of 10 or 20 donors are available. Each donor is represented by a statistically significant number of cells relative to the pool. There is extensive quality control providing characterization of viability and enzyme activity from both individual donors and the total pool. AcceGen guarantees performance and quality. Donor information is available.

声明：产品仅供科研使用